440 related articles for article (PubMed ID: 6272381)
21. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
Davis CW; Daly JW
Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
[No Abstract] [Full Text] [Related]
22. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.
Kincaid RL; Manganiello VC
Methods Enzymol; 1988; 159():457-70. PubMed ID: 2842611
[No Abstract] [Full Text] [Related]
23. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
[TBL] [Abstract][Full Text] [Related]
24. Regulation of cyclic nucleotide phosphodiesterase forms by serum and insulin in cultured fibroblasts.
Pledger WJ; Thompson WJ; Epstein PM; Strada SJ
J Cell Physiol; 1979 Sep; 100(3):497-507. PubMed ID: 226555
[TBL] [Abstract][Full Text] [Related]
25. Calmodulin and cyclic nucleotide-phosphodiesterase activities in rat mammary gland during the lactogenic cycle.
Pizarro M; Puente J; Sapag-Hagar M
FEBS Lett; 1981 Dec; 136(1):127-30. PubMed ID: 6274696
[No Abstract] [Full Text] [Related]
26. A simple direct assay of 3',5'-cyclic nucleotide phosphodiesterase activity based on the use of polyacrylamide-bononate affinity gel chromatography.
Davis CW; Daly JW
J Cyclic Nucleotide Res; 1979; 5(1):65-74. PubMed ID: 220290
[TBL] [Abstract][Full Text] [Related]
27. [Properties of cyclic nucleotide phosphodiesterase of the rabbit myometrium in various functional states].
Kurskiĭ MD; Osipenko AA; Prishchepa LA
Biokhimiia; 1984 Jul; 49(7):1096-102. PubMed ID: 6089916
[TBL] [Abstract][Full Text] [Related]
28. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
Hait WN; Weiss B
Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
[No Abstract] [Full Text] [Related]
29. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
Levin RM; Weiss B
Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
[No Abstract] [Full Text] [Related]
30. 2',3'-cyclic neucleotide 3'-phosphodiesterase activity in developing rat brain.
Singh R; Shankar R
Indian J Physiol Pharmacol; 1998 Jan; 42(1):147-50. PubMed ID: 9513810
[No Abstract] [Full Text] [Related]
31. Cyclic nucleotide phosphodiesterases.
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():1-416. PubMed ID: 6326516
[No Abstract] [Full Text] [Related]
32. Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
Manganiello VC; Yamamoto T; Elks M; Lin MC; Vaughan M
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():291-301. PubMed ID: 6326529
[No Abstract] [Full Text] [Related]
33. Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brain.
Liang CM; Liu YP; Chabner BA
Biochem Pharmacol; 1980 Feb; 29(3):277-82. PubMed ID: 6244836
[No Abstract] [Full Text] [Related]
34. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
Beatty CH; Herrington PT; Bocek RM
Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
[TBL] [Abstract][Full Text] [Related]
35. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
Piazza GA; Thompson WJ; Pamukcu R; Alila HW; Whitehead CM; Liu L; Fetter JR; Gresh WE; Klein-Szanto AJ; Farnell DR; Eto I; Grubbs CJ
Cancer Res; 2001 May; 61(10):3961-8. PubMed ID: 11358813
[TBL] [Abstract][Full Text] [Related]
36. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
Kireeva NN; Bobruskin ID; Severin SE
Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
[TBL] [Abstract][Full Text] [Related]
37. [The role of the components of the cyclic nucleotide system in N-nitrosodiethylamine-induced hepatic carcinogenesis in rats].
Antonenko SG; Berdinskikh NK; Mishnaevskaia EG
Eksp Onkol; 1990; 12(5):18-21. PubMed ID: 2171896
[TBL] [Abstract][Full Text] [Related]
38. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
39. Regulation of parotid gland function by cyclic nucleotides and calcium.
Butcher FR; Putney JW
Adv Cyclic Nucleotide Res; 1980; 13():215-49. PubMed ID: 6158259
[No Abstract] [Full Text] [Related]
40. Cyclic nucleotide phosphodiesterase activity in midpiece and tail of buffalo spermatozoa and its role in sperm motility.
Bhatnagar SK; Anand SR
Biochim Biophys Acta; 1982 May; 716(2):133-9. PubMed ID: 6284248
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]